Amelotex gel naruzhn.prim-I 1% 50g 1 piece

$5.69

Amelotex gel naruzhn.prim-I 1% 50g 1 piece

Quantity:

SKU: 1340058880 Categories: , , Tags: ,

Description

Composition
Active substance:
Meloxicam (in terms of 100% substance) – 1.0 g
Excipients:
methylpyrrolidone 15.0 g, 95% ethanol – 25.0 g, Carbomer – 0.9 g, Trometamol – 2.0 g to
(3.0 g, to pH 7,5-8,9), orange flower oil – 0.015 g, lavender oil – 0.01 g Purified water – 100.0 g
Description:
clear or almost clear gel yellow or yellow to greenish color and odor.
Product form:
Gel for external application of 1%.
50.0 g in a tube of aluminum.
1 tube together with instructions for use in a stack of cardboard.
Contraindications
Hypersensitivity to meloxicam and other ingredients (including to other NSAIDs); complete or partial combination of asthma, recurrent nasal polyposis and paranasal sinuses and intolerance to acetylsalicylic acid or other NSAIDs (including history), violation of the integrity of the skin in places intended application; children’s age (18 years) (effectiveness and safety have been established); pregnancy.
Precautions: peptic ulcer and 12 duodenal ulcer (exacerbation), active gastrointestinal bleeding; progressive renal disease, severe liver failure or active liver disease confirmed by hyperkalemia, inflammatory bowel disease, advanced age, coagulation disorder, chronic heart failure.
Dosage
1 %
Indications
Symptomatic treatment of osteoarthritis, accompanied by pain syndrome. Post-traumatic pain syndrome (traumatic injuries, sprains, damaged ligaments, muscles and tendons, muscles breaks without violating the integrity of the skin). It is used for symptomatic therapy, reduce pain and inflammation; on the progression of the disease is not affected.
Interaction with other drugs
AMELOTEKS® Gel should not be used together with other drugs for external use. It is not recommended to apply the gel in conjunction with other NSAIDs. The combined use with other dosage forms of meloxicam (tablets, injections) daily dose should not exceed 15 mg.
Overdose
Due to the low systemic absorption when applied AMELOTEKS® gel, overdose with topical unlikely.
pharmachologic effect
Pharmacological group:
nonsteroidal anti-inflammatory drug for external use.
Pharmacodynamics:
AMELOTEKS® gel contains meloxicam – a non-steroidal anti-inflammatory drug (NSAID) having analgesic, anti-inflammatory action. The anti-inflammatory action due to inhibition of the enzymatic activity of cyclooxygenase-2 (COX-2) involved in the biosynthesis of prostaglandins in inflammation. To a lesser extent meloxicam acts on cyclooxygenase-1 (COX-1) involved in prostaglandin synthesis, protecting the mucosa of the gastrointestinal tract and participate in the regulation of renal blood flow.
Meloxicam is “hondroneytralnym” drug has no negative effect on the cartilage has no effect on proteoglycan synthesis by chondrocytes of articular cartilage.
When applied topically, the drug reduces or eliminates pain in the application of the gel, including joint pain at rest and during motion. Increases the range of motion.
Pharmacokinetics:
In studies on rabbits established that meloxicam percutaneous application in gel form characterized by prolonged transdermal absorption, prolonged circulation in the blood and the gradual elimination significantly differing kinetic characteristics from the intramuscular route of administration. Evidence of substantial absorption of meloxicam into the systemic circulation is not obtained. In the systemic circulation meloxicam binds tightly to plasma proteins, mainly albumin (99%). Biotransformation in the liver to inactive metabolites. Derived mainly as metabolites in the urine and feces in approximately equal proportions.
Pregnancy and breast-feeding
Use of the drug is contraindicated during pregnancy and lactation.
Conditions of supply of pharmacies
Without a prescription.
side effects
For drugs, NSAIDs which are for external application are described in the following side effects.
For the skin: redness, rash papular, vesicular, exfoliation, photosensitivity.
Allergic reactions: itching and burning of the skin, erythema multiforme, urticaria, systemic anaphylactic reactions.
In the event of adverse reactions, including those not mentioned above, discontinue use of the gel, and also inform the attending physician.
special instructions
Requires the control of the doctor when assigning AMELOTEKS® gel elderly patients with impaired kidney function, liver, chronic heart failure, patients with bleeding stomach and duodenum 12, ulcers in acute or severe disturbances of blood coagulation.
AMELOTEKS® gel is recommended to apply only to the damaged areas of the skin, avoiding contact with open wounds. Gel contact should be avoided in the eyes and mucous membranes.
To reduce the risk of adverse reactions is necessary to use the minimum effective dose with the least duration of treatment. If the patient’s condition does not improve, they should always consult a doctor.
should not be used in patients with known hypersensitivity to NSAIDs in history. In case of hypersensitivity reactions, treatment should be discontinued.
During the period of treatment may develop photosensitivity reactions. To reduce the risk of photosensitivity, patients should avoid UV radiation and tanning facilities.
Impact on the performance of potentially hazardous activities that require attention and quickness of psychomotor reactions.
AMELOTEKS® gel does not affect the management of transport and other classes of potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
Store at a temperature not higher than 25 ° C. Do not freeze. Keep out of the reach of children
Dosing and Administration
Outwardly. Do not apply inside.
Gel strip length of about 4 cm (2 g) was applied 2 times a day with a thin layer onto the clean dry skin of lesions and lightly rubbed for 2-3 min. Duration of treatment is determined individually, may vary depending on lesion location and celebrated therapeutic effect and constitutes no more than 4 weeks.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

SOTEX

There are no reviews yet.

Add your review